TRIAL READY (Clinical Trial Readiness)
NCT03912987
ALS-Frontotemporal Dementia, Amyotrophic Lateral Sclerosis
Miami, Florida, United States
View Trial DetailsNCT Number: NCT03489278
The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.
Interested in participating?
Request Info18 year and older
All sexes
Observational
University of California, Irvine, Irvine, California, United States
The study will consent patients with ALS or related disorders that are receiving care at a clinical center in the CReATe consortium that uses Epic as its electronic health record (EHR) system. The study aims to systematically gather a clinical dataset through the EHR using a standardized approach to characterize the natural history of ALS and related diseases.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
Contact information is provided by the study sponsor or research team.
Jessica Hernandez
CONTACT
Michael Benatar, MBChB, MS, DPhil
CONTACT
University of Miami
Other
Clinical Procedures to Support Research in ALS (CAPTURE-ALS)
Acronym: CAPTURE-ALS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03912987
ALS-Frontotemporal Dementia, Amyotrophic Lateral Sclerosis
Miami, Florida, United States
View Trial DetailsNCT05204017
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Edmonton, Alberta, Canada
View Trial DetailsNCT07478172
Amyotrophic Lateral Sclerosis, Autoimmune Diseases
Columbia, Missouri, United States
View Trial DetailsNCT06315673
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Hershey, Pennsylvania, United States
View Trial Details